Urethral mobility and Point Aa of the P elvic O rgan P rolapse Q uantification ( POP‐Q ) system before and after midurethral sling operation

2018 ◽  
Vol 11 (2) ◽  
pp. O117-O120 ◽  
Author(s):  
Ho Seok Chung ◽  
Sun‐Ouck Kim ◽  
Dongdeuk Kwon
2019 ◽  
Vol 2019 ◽  
pp. 1-7 ◽  
Author(s):  
Tomasz Rechberger ◽  
Andrzej Wrobel ◽  
Alicja Zietek ◽  
Ewa Rechberger ◽  
Beata Kulik-Rechberger ◽  
...  

Aim. Lower urinary tract symptoms (LUTS) frequently affect patients immediately after midurethral sling (MUS) placement. The objective of the study was to assess if solifenacin or mirabegron decreases incidence of LUTS in women who underwent transobturator MUS. Methods. A prospective randomized trial was conducted on patients undergoing ambulatory transobturator midurethral sling due to stress urinary incontinence (SUI). All participants were questioned before and after surgery for occurrence of bothersome LUTS. A total of 328 patients who underwent transobturator MUS were randomly assigned to one of three groups: prophylaxis with 10 mg of solifenacin, prophylaxis with 50 mg of mirabegron, or without any additional treatment. LUTS evolution and efficacy of solifenacin and mirabegron were analyzed based on results of assessments made during follow-up visits at 1 and 6 weeks after surgery. Comparison of the prevalence of LUTS was done using chi2 test. Results. Prevalence of urgency and frequency episodes increased notably 1 week after sling placement and then came down to baseline levels. Solifenacin and mirabegron significantly reduced the incidence of urgency after 1 week, but after 6 weeks the beneficial effect was observed only in case of solifenacin. Treatment with mirabegron reduced the percentage of patients suffering from frequency after 6 weeks. Although prevalence of nocturia did not raise after sling placement, both treatments significantly reduced the incidence of this complaint after 6 weeks. Pharmacological treatment did not modulate the course of hesitancy and terminal dribbling. Conclusions. Treatment with solifenacin or mirabegron may significantly reduce the incidence of undesired LUTS after MUS.


2020 ◽  
Vol 28 (1) ◽  
pp. 24
Author(s):  
Mokhamad Anhar Dani ◽  
Azami Denas Azinar ◽  
Eighty Mardiyan Kurniawati ◽  
Hari Paraton ◽  
Gatut Hardianto ◽  
...  

Objectives: the aim of this study is to report the outcome of Manchester operation in cervical elongation patients with pelvic organ prolapse at Dr. Soetomo Hospital, Surabaya from January 2015 to June 2017.Case Report: During January 2015 until June 2017 there were seven patients already performed Manchester operation, however only four patients routine control. In all four cases, three cases were obtained with cervical elongation with a pelvic organ prolap (POP) and one case with cervical elongation. Perform evaluation before and after operation by using questionnaire and inspection of POP-Q system. During the evaluation there was one case with repeated lump complaints diagnosed with a uterine prolap, while one of it was with a posterior compartment prolap, but the patient did not complain during the evaluation. Both of these patients refused to reoperate after evaluation.Conclusion: After Manchester operation in cervical elongation with POP had two cases with repeated prolapse. Questionnaires and POP-Q systems were used to diagnose and evaluate preoperative and postoperative Manchester.


Sign in / Sign up

Export Citation Format

Share Document